Relating to a statewide order issued by the commissioner of state health services authorizing a pharmacist to dispense ivermectin.
Summary
SB 69 would require the Texas commissioner of state health services to issue a statewide order allowing licensed pharmacists to dispense ivermectin without a prescription from a health care practitioner. The bill directs the order to include standardized written procedures or protocols for pharmacists and to require patient instructions on proper use of the drug. It also authorizes pharmacists to dispense ivermectin under the order notwithstanding other law, and it requires annual reporting of the number of doses dispensed under the statewide order.
The bill further provides liability and disciplinary protections for pharmacists who act in a reasonably prudent manner while dispensing ivermectin under the order, and it shields the commissioner from criminal, civil, or licensing-disciplinary consequences for issuing the order. The Texas State Board of Pharmacy and the executive commissioner may adopt rules to implement the measure, and the commissioner must issue the order as soon as practicable after the act takes effect.
Impact
SB 69 would amend Chapter 1001 of the Texas Health and Safety Code by adding a new section that creates a statewide mechanism for nonprescription dispensing of ivermectin by pharmacists. It would override conflicting state-law requirements that otherwise limit dispensing to prescription orders, while also establishing reporting, protocol, and rulemaking requirements for the Department of State Health Services and the Texas State Board of Pharmacy. The bill affects pharmacists, patients seeking ivermectin, and state health regulators, and it creates explicit immunity protections tied to compliance with the statewide order.
Sentiment
Based on the bill text and the absence of committee transcripts or recorded votes, the available context suggests the measure was introduced as a policy proposal rather than one with documented public debate in the provided materials. The bill’s structure indicates support for expanding access to ivermectin through pharmacists, while also attempting to address safety and liability concerns through standardized procedures and reporting. No formal sentiment from committee discussion or voting history is available in the record provided.
Contention
The main point of contention is likely the bill’s authorization of ivermectin dispensing without a prescription, which may raise concerns about medical oversight, appropriate use, and public health policy. Supporters would likely emphasize expanded access and pharmacist discretion, while opponents may object to bypassing a health care practitioner’s prescription order and to the broader implications of state endorsement of ivermectin use. The bill also anticipates concern over legal exposure by granting immunity to pharmacists and the commissioner, suggesting liability and professional accountability are central issues.
Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.
Authorizes statewide municipal reciprocal program agreements and the issuance of program bonds; authorizes proceeds to be made available to a statewide municipal reciprocal program.